Metreleptin, therefore, bypasses the possibility of leptin resistance due to its indication for patients only with genetic defects in leptin who lack central leptin resistance, a type of resistance seen in nongenetic obesity. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.